16.  Martewicz S., Magnussen M., Elvassore N. (2020) ‘Beyond Family: modeling non-hereditary heart diseases with human pluripotent stem cell-derived cardiomyocytes.’ Frontiers in Physiology, 2020, 11:384 doi: 10.3389/fphys.2020.00384


15. Dong, Y.Cui, M.; Qu, J.; Wang, X.; Kwon, S.H.; Barrera, J.; Elvassore, N.; Gurtner, C.G. ‘Conformable hyaluronic acid hydrogel delivers adipose-derived stem cells and promotes regeneration of burn injury’. Acta Biomaterialia, 2020, 108:55-56.


14.  Giobbe G.G.*, Crowley C.*, Luni C.*, Campinoti S., Khedr M., Kretzschmar K., De Santis M.M., Zambaiti, E., Hu Q., Michielin F., Meran L., Urbani L., Manfredi A., van Son G., Eaton S., Cacchiarelli D., Li V.S.W., Clevers H., Bonfanti P., Elvassore N.#, De Coppi P.# Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoid culture. Nature Communications. 2019, 10:5658.


13.  Tonon F.*, Giobbe G.G.*, Zambon A., Luni C., Gagliano O., Floreani A., Grassi G., Elvassore N. In vitro metabolic zonation through oxygen gradient on a chip. Scientific Reports. 2019, 9:13557. doi: 10.1038/s41598-019-49412-6.


12.  Gagliano O.*,Luni C.*,Qin W., Bertin E.,Torchio E.,Galvanin S., Urciuolo A.,Elvassore N. Microfluidic reprogramming to pluripotency of human somatic cells. Nature Protocols. 2019, 14:722–737. doi: 10.1038/s41596-018-0108-4.


11.  Beninatto R., Barbera C., De Lucchi O., Borsato G., Serena E., Guarise C., Pavan M.,Luni C.,Martewicz S., Galesso D.,Elvassore N.Photocrosslinked hydrogels from coumarin derivatives of hyaluronic acid for tissue engineering applications. Materials Science and Engineering: C. 2019, 96:625-634. doi:10.1016/j.msec.2018.11.052.


10.  Giulitti S, Pellegrini M, Zorzan I, Martini P, Gagliano O, Mutarelli M, Ziller MJ, Cacchiarelli D, Romualdi C, Elvassore N, Martello G.  Direct generation of human naive induced pluripotent stem cells from somatic cells in microfluidics. Nature Cell Biology. 2019, 21:275-286. doi: 10.1038/s41556-018-0254-5.


9.  Zoso A., Zambon A., Gagliano O., Giulitti S., Prevedello L., Fadini G.P.,Luni C.,Elvassore N. Cross-talk of healthy and impaired human tissues for dissection of disease pathogenesis. Biotechnology Progress. 2018, 35:e2766. doi:10.1002/btpr.2766.


8.  Martewicz S.*,Luni C.*, Serena E., Pavan P., Chen V. H.-S., Rampazzo A.,Elvassore N. Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli. Ann Biomed Eng. 2018, 47:852-865. doi: 10.1007/s10439-018-02134-8.


7.  Prevedello L., Michielin F., Balcon M.,Savio E., Pavan P., Elvassore N. A novel microfluidic platform for biomechano-stimulations on a chip. Ann Biomed Eng. 2018, 47:231-242. doi: 10.1007/s10439-018-02121-z.


6.  Dong, Y.; Rodrigues, M.; Kwon, S.H.; Li, X.; A, S.; Brett, E.A.; Elvassore, N.; Wang, W.; Gurtner, C.G. Acceleration of diabetic wound regeneration using an in-situ-formed stem cell-based skin substitute’. Advanced Healthcare Materials. 2018, 7(17):e1800432. doi: 10.1002/adhm. 201800432.


5.  Martewicz S, Gabrel G, Campesan M, Canton M, Di Lisa F, Elvassore N. Live Cell Imaging in Microfluidic Device Proves Resistance to Oxygen/Glucose Deprivation in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Anal Chem. 2018, 90(9):5687-5695.doi: 10.1021/acs.analchem.7b05347.


4.  Hu Q.,Luni C.,Elvassore N.Microfluidics for secretome analysis under enhanced endogenous signaling. Biochem Biophys Res Commun. 2018, 497(2):480-484 doi: 10.1016/j.bbrc.2018.02.025.


3.  Martewicz S., Serena E., Zatti S., Keller G., Elvassore N. Substrate and mechanotransduction influence SERCA2a localization in human pluripotent stem cell-derived cardiomyocytes affecting functional performance. Stem Cell Research.2017, 25:107-114 doi: 10.1016/j.scr.2017.10.011.


2.  Scattolini V.*, Luni C.*, Zambon A., Galvanin S., Gagliano O., Ciubotaru C.D., Avogaro A., Mammano F.,Elvassore N., and Fadini G.P. Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures. Diabetes Ther. 2016, 7(4):679-693 doi: 10.1007/s13300-016-0210-y.


1.  Gagliano O., Elvassore N., and Luni C. Microfluidic technology enhances the potential of human pluripotent stem cells. Biochem Biophys Res Commun.2016, 473(3):683-687 doi: 10.1016/j.bbrc.2015.12.058.